3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.Borderline Resectable Pancreatic Ductal AdenocarcinomaNot yet recruitingPhase 22026-06-11NCT07616362
Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderNot yet recruitingPhase 22025-09-08NCT07150403
A French Multicenter Observational Retrospective Study of Rare Primary Liver CancersDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, combined hepatocellular carcinoma and cholangiocarcinoma, epithelial neoplasm, fibrolamellar hepatocellular carcinoma, hepatoblastoma, liver disorder, liver neuroendocrine carcinoma, mixed neoplasm, neoplasmRecruitingNot stated2025-08-05NCT06541652